Singapore HIV, Hepatitis and STI Congress (SHHSC) 2026
6 March 2026

Singapore HIV, Hepatitis, and STI Congress (SHHSC) 2026
The SHHSC is the inaugural flagship event presented by the HIV, Hepatitis and STI (HHS) division under the Communicable Diseases Agency. It is dedicated to advancing innovative approaches and highlighting the latest developments in HHS management.
SHHSC 2026 will convene international keynote speakers, community programme showcases, and innovative research presentations delivered through both oral and poster presentations.
The theme for this year’s SHHSC is Charting the Path Forward: New Beginnings Through Collaboration, which reflects the congress’s focus on shaping the future of HHS management driven by new scientific advances, innovative programmes, and fresh partnerships.
Join us for SHHSC 2026 to experience innovative research presentations, policy discussions, community programme showcases, and networking opportunities with healthcare professionals, researchers, and community partners.
Register via the link: https://go.gov.sg/shhsc-registration
Registration for SHHSC is now closed. All successful applicants will receive an email from SHHSC Secretariat shortly. For all queries, please contact SHHSC@cda.gov.sg
Event Overview
Date | 23 May 2026, Saturday |
Time | 9:00am – 6:00pm |
Venue | Aloft Singapore Novena (West Wing) 16 Ah Hood Road, Level 2, Singapore 329982 |
Guest of Honour | Mdm Rahayu Mahzam Minister of State, Ministry of Digital Development and Information & |
Theme | Charting the Path Forward: New Beginnings Through Collaboration |
3 Focus Tracks |
|
Participation fee | Free |
Guest Of Honour
Mdm Rahayu Mahzam
Minister of State, Ministry of Digital Development and Information &
Ministry of Health
Keynote Speakers

Professor Eric Chow
Head, Health Data Management and Biostatistics Unit, Melbourne Sexual Health Centre, Bayside Health
President, The International Society for Sexually Transmitted Diseases Research
Director, The Australian Society for Medical Research
Professor Eric Chow is an STI epidemiologist based at the Melbourne Sexual Health Centre and Monash University. He heads the Health Data Management and Biostatistics Unit and co-leads the HIV/STI Clinical Trials Unit. His research focuses on improving the prevention, diagnosis, and control of STIs, with particular interests in male HPV vaccination, gonorrhoea transmission dynamics, doxycycline post-exposure prophylaxis (doxyPEP) and the application of digital and AI tools in sexual health.
Eric has published over 450 peer-reviewed papers, informs national and international policy. He has recently completed the DoxyAWARE study in Australia and is currently leading the DoxyAsia study across 16 countries/regions in Asia. Together, these studies examine awareness, uptake, safety, and clinical practices related to doxyPEP across diverse healthcare settings.
He is also leading an international study evaluating AI-assisted decision support for the diagnosis of anogenital skin conditions. He was named Australia’s top researcher in the field of Sex & Sexuality (2024). He is President of the International Society for Sexually Transmitted Diseases Research (ISSTDR) and serves on the executive board of the Australasian Sexual and Reproductive Health Alliance (ASRHA).

Associate Professor Raja Iskandar Shah Raja Azwa
Consultant, Infectious Diseases
Director, Centre of Excellence for Research in Infectious Diseases of AIDS, Faculty of Medicine, Universiti Malaya
President, Malaysian AIDS Council
Associate Professor Raja Iskandar Shah Raja Azwa is an Associate Professor of Infectious Diseases and is the Clinical Lead for the HIV service in the Infectious Diseases Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur. He is also the Director of the Centre of Excellence for Research in Infectious Diseases & AIDS (CERIA), Faculty of Medicine, Universiti Malaya.
His research interests include HIV Pre-exposure prophylaxis (PrEP) implementation research and stigma reduction interventions among key populations and evaluation of novel second line HIV treatment strategies in resource-limited settings. He is the site Principal Investigator (PI) for several international collaborative HIV clinical trials which have shaped HIV guidelines locally and globally. Much of his recent work has focused on increasing community access to HIV prevention biomedical interventions and implementation of differentiated service delivery models of HIV care & prevention including m-health and pharmacy-led service delivery models. He has been a member of several WHO Guidelines development groups on HIV treatment and prevention since 2020.
Iskandar Azwa also serves as the current President of the Malaysian AIDS Council.
Scientific Committee Members
Our scientific committee members are selected for their expertise in HIV, Hepatitis, and STIs, and representing CDA, public healthcare institutions, and community-based organisations, they ensure the congress delivers content that is both scientifically rigorous and practically relevant.

Programme Outline
Time | Segment |
0830 – 0915 | Registration |
0915 – 0920 | Welcome address: Assoc Prof Dr Pek Wee Yang |
0920 – 0930 | Opening address: Guest of Honour, Mdm Rahayu Mahzam |
0930 – 1015 | Keynote Presentation 1: Assoc Prof Dr Raja Iskandar Shah "Redefining HIV Care in 2026: Long-Acting Antiretroviral Therapy and Integrated Management of STIs, hepatitis and Comorbidities" |
1015 – 1035 | Tea break |
1035 – 1150 | Breakout session 1 |
1150 – 1330 | Lunch |
1330 – 1445 | Breakout session 2 |
1445 – 1545 | Oral Presentation |
1545 – 1600 | Tea break |
1600 – 1615 | The road to 95-95-95: |
1615 – 1700 | Keynote Presentation 2: Prof Eric Chow "Redesigning HIV and sexual health care in the era of artificial intelligence" |
1700 – 1745 | Closing debate: "This House believes that the future of HIV, Hepatitis and STI responses lies in artificial intelligence" |
1745 – 1750 | Closing address: Adj Asst Prof Dr Wong Chen Seong |
More information on the breakout sessions such as speakers and topics can be found here
Call for Abstracts
The SHHSC 2026 secretariat invites abstract submissions that advance clinical practice, public health policy, and community responses related to HIV, Hepatitis, and STIs.
Abstract submissions are now closed.
The SHHSC secretariat will contact the authors of the accepted submission by 18 April 2026 [Do note of the date extension].



